GlaxoSmithKline has closed shop at an aging facility in Bangladesh, triggering layoffs for about 1,000 employees.
The company said the nearly 60-year-old plant in Fouzderhat has been operating at a loss for years, partly due to competition from generics and low-cost medicine imports from China. It is also equipped with outdated machinery.
“GSK was struggling to maintain its global standard at the factory,” a director of the company’s board reportedly stated.
Around 500 employees protested upon receiving the news. The company stated that it would provide support to the employees during the transition.
Last year, the company announced plans to rework operations in emerging markets.
Read the full Daily Star report.